Journey Strategic Wealth LLC Invests $84,000 in Hyperfine, Inc. (NASDAQ:HYPR)

Journey Strategic Wealth LLC purchased a new position in shares of Hyperfine, Inc. (NASDAQ:HYPRFree Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 74,929 shares of the company’s stock, valued at approximately $84,000.

A number of other large investors have also made changes to their positions in HYPR. Citigroup Inc. acquired a new position in shares of Hyperfine in the 3rd quarter valued at $29,000. Knollwood Investment Advisory LLC acquired a new position in shares of Hyperfine in the 3rd quarter valued at $41,000. EP Wealth Advisors LLC acquired a new position in shares of Hyperfine in the 3rd quarter valued at $71,000. Signaturefd LLC acquired a new position in shares of Hyperfine in the 3rd quarter valued at $102,000. Finally, Bank of New York Mellon Corp increased its position in shares of Hyperfine by 304.3% in the 3rd quarter. Bank of New York Mellon Corp now owns 219,582 shares of the company’s stock valued at $450,000 after acquiring an additional 165,269 shares during the period. 15.03% of the stock is owned by institutional investors and hedge funds.

Hyperfine Trading Up 7.7 %

Shares of HYPR stock traded up $0.07 during mid-day trading on Wednesday, hitting $0.96. 298,036 shares of the stock were exchanged, compared to its average volume of 76,317. The firm has a fifty day moving average of $0.94 and a 200 day moving average of $1.06. Hyperfine, Inc. has a 52-week low of $0.76 and a 52-week high of $3.28.

Hyperfine (NASDAQ:HYPRGet Free Report) last posted its earnings results on Thursday, March 21st. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.17) by $0.02. Hyperfine had a negative net margin of 358.59% and a negative return on equity of 46.96%. The business had revenue of $2.69 million for the quarter, compared to analyst estimates of $3.66 million. As a group, equities analysts forecast that Hyperfine, Inc. will post -0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Wells Fargo & Company lowered their price target on shares of Hyperfine from $2.10 to $1.60 and set an “equal weight” rating on the stock in a report on Friday, March 22nd.

View Our Latest Stock Analysis on HYPR

Hyperfine Company Profile

(Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Read More

Want to see what other hedge funds are holding HYPR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hyperfine, Inc. (NASDAQ:HYPRFree Report).

Institutional Ownership by Quarter for Hyperfine (NASDAQ:HYPR)

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.